Related content

CD2AP is associated with end-stage renal disease in patients with type 1 diabetes

By Hyvönen Mervi   Ihalmo Pekka   Sandholm Niina   Stavarachi Monica   Forsblom Carol   McKnight Amy   Lajer Maria   Maestroni Anna   Lewis Gareth   Tarnow Lise   Maestroni Silvia   Zerbini Gianpaolo   Parving Hans-Henrik   Maxwell Alexander   Groop Per-Henrik   Lehtonen Sanna  

Acta Diabetologica, Vol. 50, Iss. 6, 2013-12 ,pp. : 887-897

Springer Publishing Company

Access to resources Recommend Favorite

A deficiency of gastric interstitial cells of Cajal accompanied by decreased expression of neuronal nitric oxide synthase and substance P in patients with type 2 diabetes mellitus

By Iwasaki Hirohiko   Kajimura Masayoshi   Osawa Satoshi   Kanaoka Shigeru   Furuta Takahisa   Ikuma Mutsuhiro   Hishida Akira  

Journal of Gastroenterology, Vol. 41, Iss. 11, 2006-11 ,pp. : 1076-1087

Springer Publishing Company

Access to resources Recommend Favorite

Performance of the revised ‘175’ Modification of Diet in Renal Disease equation in patients with type 2 diabetes

By Chudleigh R.   Ollerton R.   Dunseath G.   Peter R.   Harvey J.   Luzio S.   Owens D.  

Diabetologia, Vol. 51, Iss. 9, 2008-09 ,pp. : 1714-1718

Springer Publishing Company

Access to resources Recommend Favorite

Modified end-stage renal disease risk score for Chinese type 2 diabetic patients—the Hong Kong Diabetes Registry

By Yang X.   So W.   Kong A.   Ho C.   Lam C.   Ng M.   Lyu R.   Yin D.   Chow C.   Cockram C.   Tong P.   Chan J.  

Diabetologia, Vol. 50, Iss. 6, 2007-06 ,pp. : 1348-1350

Springer Publishing Company

Access to resources Recommend Favorite

Diabetic Renal Disease in Patients with Type 2 Diabetes Mellitus: New Strategies for Prevention and Treatment

By Mogensen C.E.  

Treatments in Endocrinology, Vol. 1, Iss. 1, 2002-01 ,pp. : 3-11

Adis International

Access to resources Recommend Favorite